Scholarlink

<p>Resistance to insecticides and associated behavioural shifts are being increasingly reported in malaria vectors. To counter these adaptations, there is a pressing need to explore novel control tools and interventions. In line with this, the present study evaluates the potential of ivermectin as a contact-toxin for both malaria vectors and parasite. Laboratory reared female <i>An. culicifacies</i> and <i>An. stephensi</i> mosquitoes were exposed to different concentrations of ivermectin through topical and bottle bioassays. Mortality data was used to calculate the LD<sub>50</sub> and LD<sub>90</sub> values. Infection studies with <i>Plasmodium berghei</i> were done in female <i>An. stephensi</i> to check the transmission blocking activity of ivermectin. Following contact exposure to ivermectin, the midguts of exposed mosquitoes were dissected and oocysts were counted to calculate oocyst intensity and prevalence. Ivermectin demonstrated high contact toxicity against both <i>An. stephensi</i> and <i>An. culicifacies</i> mosquitoes inducing 100% mortality in both vector species within 24–48&#xa0;h of exposure at higher dosages of ivermectin. In topical bioassay, after 48&#xa0;h the LD<sub>50</sub> value for <i>An. stephensi</i> and <i>An. culicifacies</i> was 0.017&#xa0;ng/mg (95% CI 0.008–0.30) and 0.002&#xa0;ng/mg (95% CI 0.000–0.005) respectively. The corresponding LD<sub>90</sub> values were 0.264&#xa0;ng/mg (95% CI 0.138–.703) and 0.174&#xa0;ng/mg (95% CI 0.063–1.173) for <i>An. stephensi</i> and <i>An. culicifacies.</i> Whereas in bottle bioassay after 48&#xa0;h, the LD<sub>50</sub> value for <i>An. stephensi</i> and <i>An. culicifacies</i> was 4.245&#xa0;µg/bottle (95% CI 3.018-5.715) and 1.768&#xa0;µg/ bottle (95% CI 1.211-2.528) respectively. The LD<sub>90</sub> value of <i>An. stephensi</i> and <i>An. culicifacies</i> was 13.10&#xa0;µg/bottle (95% CI 10.56-17.50) and 5.218&#xa0;µg/ bottle (95% CI 4.02-7.63). Additionally, contact exposure to ivermectin significantly impaired oocyst development in mosquitoes. A reduction of 71% in oocyst numbers was observed at 0.01&#xa0;µM concentration of ivermectin. Our study establishes ivermectin as an effective contact mosquitocidal and transmission blocking agent. These findings further contribute to the growing body of evidence supporting the use of ivermectin as a novel vector control tool capable of simultaneously reducing vector population and interrupting malaria transmission.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Contact exposure to ivermectin induces acute mortality and inhibits parasite development in malaria vectors

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月31日

查看全文
  • Meenakshi Jeena,
  • Bharti Goyal,
  • Suman Lata,
  • Gaurav Kumar,
  • Lipun Kumar Pradhan,
  • Yamini Thakur,
  • Gaganpreet Kaur,
  • Vaishali Verma,
  • Kailash C. Pandey,
  • Shweta Pasi,
  • Jaspreet Kaur

摘要

Resistance to insecticides and associated behavioural shifts are being increasingly reported in malaria vectors. To counter these adaptations, there is a pressing need to explore novel control tools and interventions. In line with this, the present study evaluates the potential of ivermectin as a contact-toxin for both malaria vectors and parasite. Laboratory reared female An. culicifacies and An. stephensi mosquitoes were exposed to different concentrations of ivermectin through topical and bottle bioassays. Mortality data was used to calculate the LD50 and LD90 values. Infection studies with Plasmodium berghei were done in female An. stephensi to check the transmission blocking activity of ivermectin. Following contact exposure to ivermectin, the midguts of exposed mosquitoes were dissected and oocysts were counted to calculate oocyst intensity and prevalence. Ivermectin demonstrated high contact toxicity against both An. stephensi and An. culicifacies mosquitoes inducing 100% mortality in both vector species within 24–48 h of exposure at higher dosages of ivermectin. In topical bioassay, after 48 h the LD50 value for An. stephensi and An. culicifacies was 0.017 ng/mg (95% CI 0.008–0.30) and 0.002 ng/mg (95% CI 0.000–0.005) respectively. The corresponding LD90 values were 0.264 ng/mg (95% CI 0.138–.703) and 0.174 ng/mg (95% CI 0.063–1.173) for An. stephensi and An. culicifacies. Whereas in bottle bioassay after 48 h, the LD50 value for An. stephensi and An. culicifacies was 4.245 µg/bottle (95% CI 3.018-5.715) and 1.768 µg/ bottle (95% CI 1.211-2.528) respectively. The LD90 value of An. stephensi and An. culicifacies was 13.10 µg/bottle (95% CI 10.56-17.50) and 5.218 µg/ bottle (95% CI 4.02-7.63). Additionally, contact exposure to ivermectin significantly impaired oocyst development in mosquitoes. A reduction of 71% in oocyst numbers was observed at 0.01 µM concentration of ivermectin. Our study establishes ivermectin as an effective contact mosquitocidal and transmission blocking agent. These findings further contribute to the growing body of evidence supporting the use of ivermectin as a novel vector control tool capable of simultaneously reducing vector population and interrupting malaria transmission.